Lotrafilcon B contact lens
DeviceCommercially marketed, silicone hydrogel, multifocal contact lens for daily wear use.
Other names: AIR OPTIX AQUA MULTIFOCAL
NCT Number: NCT01371539
The purpose of this study was to compare visual performance measures between two multifocal contact lenses on presbyopic wearers.
Looking for future studies?
Notify Me35 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use.
Other names: AIR OPTIX AQUA MULTIFOCAL
Commercially marketed (France), silicone hydrogel, multifocal contact lens for daily wear use.
Other names: Biofinity Multifocal
Time frame: 1 week
The participant read a Snellen chart at a 20-foot equivalent distance with both eyes together while wearing study lenses. The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution). A 20/20 Snellen acuity equated to a logMAR acuity of 0.0 and was considered normal distance eyesight. A positive logMAR value indicated poorer vision, and a negative value denoted better visual acuity.
Time frame: 1 week
The participant read a Snellen chart at 40 centimeters with both eyes together while wearing study lenses. The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution). A 20/20 Snellen acuity equated to a logMAR acuity of 0.0 and was considered normal near eyesight. A positive logMAR value indicated poorer vision, and a negative value denoted better visual acuity.
CIBA VISION
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06869044
Eye Diseases, Hyperopia
Berkeley, California, United States
View Trial DetailsNCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT05735990
Cataract, Eye Diseases
Almería, Spain
View Trial DetailsNCT05431868
Behavior, Cataract
Beijing, Beijing Municipality, China
View Trial Details